Leaders in Ion Channel Drug Discovery
Metrion Biosciences is a specialist ion channel contract research organisation providing drug discovery services to pharmaceutical and bioscience customers worldwide.
Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Screening Service
Download our new GLP hERG Screening brochure
Metrion Biosciences
Latest News
Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Screening Service
1st August 2023
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced it has received notification from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) that the Company is now a member of the UK GLP (Good Laboratory Practice) Compliance Monitoring Programme, and is therefore able to offer GLP compliant hERG ion channel screening services to the global life sciences community.
Metrion Biosciences expands Senior Leadership Team with appointments of Dr Robert Kirby as COO and Dr Eddy Stevens as CSO
6th July 2023
Metrion Biosciences Limited (“Metrion”), the specialist ion
channel contract research and drug discovery company, today announced the appointments of Dr Robert Kirby to Chief Operating Officer and Dr Edward Stevens to Chief Scientific Officer.
Our Services
Ion Channel Screening
Cardiac Safety Screening
Neuroscience
Translational Assays
Integrated Drug Discovery
Video
Metrion Biosciences’ Neuroscience Services
6th July 2023
Here we share a short video introducing Metrion’s Neuroscience service capabilities. To learn more, or to request a quote, please email info@metrionbiosciences.com
- ‘Let’s Cure CLCN4’ rare disease channelopathy drug discovery symposium report
- Molly – My Placement At Metrion So Far
- The CICF 2023 – My Perspectives
- Jack – My Academic and Professional Career So Far!
- Zeki – From Ants to Ion Channels
- Thomas’s Career So Far
Metrion Biosciences
Upcoming Events
Drug Discovery for Ion Channels XXIV (Satellite meeting of BPS 2024)
February 9th
Metrion Biosciences will be sponsoring and attending the satellite meeting Drug Discovery for Ion Channels XXIV, part of the annual Biophysical Society Annual Meeting. This event takes place at Room 107AB, Pennsylvania Convention Center.
Metrion’s VP, Drug Discovery and Safety Assessment Dr. Steve Jenkinson and Head of Business Development, Europe Sophie Rose will be in attendance at the event. If you would like to arrange a meeting with them please contact info@metrionbiosciences.com.
SLAS 2024
February 3rd to 7th
Metrion Biosciences will be attending the: SLAS2024 International Conference and Exhibition which will be held at the Convention and Exhibition centre in Boston, MA.
Metrion will have delegate representation at the event. If you would like to arrange a meeting with the Metrion Team please contact info@metrionbiosciences.com.
This year’s scientific program will bring you more than 150 scientific talks spanning nine educational tracks within life sciences, technology and laboratory automation. Sessions will build off of the innovative, life-changing and sometimes surprising discoveries from over the last year.
Our DisPATCHes Newsletter
Receive the latest Ion Channel news and insights to your inbox
Our quarterly newsletter is packed full of the latest Ion Channel news and reviews. We cover events, webinars, research findings, and publications and insights from our team, partners, and distinguished guests. Read the latest edition here.
Let’s work together
What are your specific ion channel and assay needs?
If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.